Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

[Prostacyclin in hypertension].

¹Abt. Klinische Pharmakologie, Medizinische Hochschule Hannover.

Zeitschrift Fur Kardiologie

|June 1, 1992

Summary

This summary is machine-generated.

Prostacyclin (PGI2) causes vasodilation and inhibits platelet aggregation. However, it is ineffective as an antihypertensive agent due to side effects and complex interactions with renin secretion in hypertensive patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[Not Available].

MMW Fortschritte der Medizin·2016

Same author

[Ginseng. Does it really help?].

MMW Fortschritte der Medizin·2013

Same author

[Magnesium is no longer effective: calf cramps are becoming more severe].

MMW Fortschritte der Medizin·2012

Same author

[Is there an improvement of drug safety in Germany in recent years?].

Der Internist·2009

Same author

Effects of normalization of plasma testosterone levels in hypogonadal men on plasma levels and urinary excretion of asymmetric dimethylarginine (ADMA).

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme·2008

Same author

[Fear of dependency and habituation. Prejudices and an obstacle to NSAID treatment].

MMW Fortschritte der Medizin·2005

Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016

Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016

Same journal

[On pathogenesis of coronary heart disease].

Zeitschrift fur Kardiologie·2016

Same journal

An overview of the evolution of the atherosclerotic plaque: from fatty streak to plaque rupture and thrombosis.

Zeitschrift fur Kardiologie·2016

Same journal

[Not Available].

Zeitschrift fur Kardiologie·2016

Same journal

[Reconstructive surgery of the aortic root].

Zeitschrift fur Kardiologie·2016

See all related articles

Area of Science:

Cardiovascular Physiology
Endocrinology
Pharmacology

Context:

Prostacyclin (PGI2) mediates vasodilation and platelet inhibition via receptor pathways.
Cyclic AMP (cAMP) is a known second messenger for PGI2's antiplatelet effects.
Recent findings suggest hyperpolarization contributes to PGI2's vascular actions.

Purpose:

To investigate the mechanisms of prostacyclin (PGI2) action on blood vessels and blood pressure.
To evaluate the efficacy and side effects of PGI2 as an antihypertensive agent.
To explore the role of endogenous PGI2 synthesis in hypertension and the effects of drugs on its production.

Summary:

PGI2 infusion in healthy individuals lowers blood pressure only at doses causing significant side effects.

Related Experiment Videos

In hypertensive patients, PGI2's blood pressure effects are complex, influenced by renin secretion and sympathetic activation, rendering it unsuitable for hypertension treatment.

Vascular PGI2 is synthesized by both endothelial and smooth muscle cells; reduced synthesis is observed in pregnancy-induced and essential hypertension.

Certain antihypertensive drugs may stimulate PGI2 synthesis, while cyclooxygenase inhibitors can reduce its effects.

Impact:

Prostacyclin (PGI2) is not a viable antihypertensive therapy due to side effects and complex physiological interactions.
Understanding endogenous PGI2 synthesis and its modulation by drugs offers insights into hypertension management.
Further research into PGI2 pathways may reveal novel therapeutic targets for cardiovascular diseases.